Nn9535-4352
Research payments
$9,974,742
Through program year 2025, $9,974,742 in research payments was reported against Nn9535-4352, across 26,044 payments.
- Paid by (largest first)
- Novo Nordisk AS; Novo Nordisk Inc
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $631,926 | 426 |
| 2024 | Research | $1,083,728 | 2,889 |
| 2023 | Research | $1,346,637 | 4,120 |
| 2022 | Research | $1,472,097 | 5,516 |
| 2021 | Research | $1,757,446 | 5,472 |
| 2020 | Research | $1,956,995 | 5,245 |
| 2019 | Research | $1,725,914 | 2,376 |
Breakdown
Usually the institution or organisation running the study, not a person.
Only reported on some payments, and a payment can report more than one category, so these amounts overlap.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ildiko Lingvay Dallas, TX Named on 2,411 payments
- Steven Barag Rancho Cucamonga, CA Named on 406 payments
- Athena Philis-Tsimikas San Diego, CA Named on 402 payments
- Osama Hamdy Boston, MA Named on 387 payments
- Ronald Chochinov Ventura, CA Named on 386 payments
- Julio Rosenstock Dallas, TX Named on 384 payments
- Isaac Beshay Costa Mesa, CA Named on 360 payments
- Vicki Kalen Tucson, AZ Named on 342 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.